Quick Answer
Insight Molecular Diagnostics Inc. reported Shares Outstanding of 28.68 million shares for fiscal year 2025.
Insight Molecular Diagnostics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 28.68M | +64.3% |
| 2024 | 17.45M | +111.3% |
| 2023 | 8.26M | +39.3% |
| 2022 | 5.93M | -93.6% |
| 2021 | 92.23M | +33.4% |
| 2020 | 69.12M | +21.2% |
| 2019 | 57.03M | +40.3% |
| 2018 | 40.66M | +29.3% |
| 2017 | 31.45M | +9.4% |
| 2016 | 28.74M | +13.2% |
| 2015 | 25.39M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 28.63M | +114.0% | +0.0% |
| June 30, 2025 | 28.62M | +114.1% | +0.1% |
| March 31, 2025 | 28.60M | +245.7% | +63.9% |
| December 31, 2024 | 17.45M | +111.3% | +30.5% |
| September 30, 2024 | 13.37M | +61.9% | +0.0% |
| June 30, 2024 | 13.37M | +62.2% | +61.6% |
| March 31, 2024 | 8.27M | -93.1% | +0.1% |
| December 31, 2023 | 8.26M | +39.3% | +0.0% |
- Insight Molecular Diagnostics Inc. showed an increase of +64.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Insight Molecular Diagnostics Inc.’s shares outstanding has grown by 13.0% (from 25.39 million shares to 28.68 million shares).
- The most recent figure is from Insight Molecular Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: